Bone Journal

•  
• Overview
•  
• Identity
•  
• View All
•  

Overview

publication venue for

• Frailty and Risk of Fractures in Patients with Rheumatoid Arthritis: Data from the Ontario Best Practices Research Initiative (OBRI) 2017
• Atypical Femoral Fractures: Radiographic and Histomorphometric Features in 19 Patients 2014
• Evidence for diminished skeletal load response in women who fracture early vs. those who fracture late in life 2012
• Evidence for diminished skeletal load response in women who fracture early vs. those who fracture late in life 2012
• Participation in strenuous sports reduces stance stress at the medial femoral neck in Canadian men and women 2011
• Peripheral quantitative ultrasound for the prediction of fracture over five years: The Canadian Multicentre Osteoporosis Study (CAMOS) 2011
• Direct anti-cancer effect of oncostatin M on chondrosarcoma 2011
• Examination of the mechanism(s) of cancer-induced bone pain in animal models 2011
• Glutamate release in bone metastasis 2011
• The role of parathyroid hormone-related protein in giant cell tumour of bone 2011
• Natural History of Metastatic Bone Disease in Breast Cancer Based on Site of Bone Lesions 2010
• Significantly Reduced Burst Release by Sequestration of Protein Delivery Vehicle Within Unique Three-Phase Composite Scaffold for Bone Tissue Engineering and Regenerative Medicine 2010
• Incident vertebral compression 1 year following glucocorticoid initiation among children with rheumatic conditions: Results of a National Chronic Illness Osteoporosis Surveillance Program 2009
• Prevalent vertebral compression in children with newly diagnosed rheumatic conditions: Results of a national chronic illness osteoporosis surveillance program 2009
• Short-term skeletal changes in children with newly diagnosed glucocorticoid-treated nephrotic syndrome 2009
• Appropriate X-ray ordering depends on physician characteristics: Canadian Quality Circle (CQC) national project 2009
• Hip and vertebral fractures increase mortality rates in Canadians 2009
• The impact of physician characteristics on bone mineral density ordering: Canadian Quality Circle (CQC) national project 2009
• Failure to perceive increased risk of fracture in women aged 55 years and older. The global longitudinal study of osteoporosis in women 2009
• Disease and treatment parameters significantly affect skeletal complications and survival in metastatic breast cancer 2008
• Early and sustained non-vertebral fracture efficacy with risedronate 2008
• Towards understanding of trabecular bone failure by deformation localisation 2008
• Bone health status in relation to body adiposity in obese children and youth enrolled in a hospital-based weight management program 2007
• In vitro analysis of human femoral cancellous bone as a viable source of osteoprogenitor cells and the effects of bone morphogenetic protein 2 and doxycycline on their differentiation into bone forming colonies 2007
• Teriparatide improves osteoporosis related fracture pain 2007
• Vitamin D deficiency is common in children with renal disease 2007
• Why do patients with metastatic breast cancer (MBC) continue to have bone destruction despite bisphosphonate (BP) use? A pathologic review 2006
• Family physicians' awareness of osteoporosis risk factors and utilization of bone mineral density (BMD) screening following a multifaceted osteoporosis intervention strategy: Canadian quality circle (CQC) pilot project 2005
• Multisite ultrasound and vertebral deformity: Findings from the Canadian Multicentre Osteoporosis Study (CaMoS) 2005
• The assessment of process factors involved in conducting the Canadian Quality Circle (CQC) pilot project for the care of patients at risk for osteoporosis (OP) 2005
• The rate that family physicians prescribe osteoporosis medications to their patients: Canadian Quality Circles (CQC) Project 2005
• Bone mineral status after treatment of malignant lymphoma in childhood and adolescence 2005
• Children on long term warfarin have decreased bone mineral density 2005
• Effect of diagnostic radioisotopes (DR) and radiographic contrast media (RCM) on measurements of body composition by dual energy X-ray absorptiometry (DXA) in children with cancer 2005
• Femoral neck bone mass, geometry and strength in male pre-pubertal athletes with differential loading 2005
• Osteopenia, physical activity and health-related quality of life in survivors of brain tumors treated in childhood 2005
• Use of alendronate to treat reduced bone mineral mass in children surviving acute lymphoblastic leukemia (ALL) 2005
• Effect of silicon on survival and cell proliferation in human osteoblast-like Saos-2 cells 2004
• Gastrointestinal adverse events can reduce compliance with oral bisphosphonate therapy and result in early study termination 2004
• Safety and convenience of bisphosphonate infusions 2004
• Survival-adjusted cumulative event analysis of skeletal-related events in patients with cancer metastatic to bone in trials of zoledronic acid 2004
• Estimated bone mineral density, diet and exercise in female students at the University of Sharjah, United Arab Emirates 2003
• Growth-related changes in bone strength and site-specific geometry at the mid-femur determined by MRI 2003
• Patient characteristics that predict the time to first clinically recognized vertebral deformity in postmenopausal women enrolled the Canadian multicentre osteoporosis study (CaMos) 2003
• Risk factors that predict the time to first nonvertebral fracture in postmenopausal women recruited from the Canadian multicentre osteoporosis study (CaMos) 2003
• The association between osteoporotic fractures and health related quality of life (HRQL) as measured by the health utilities index Mark II and Mark III systems 2003
• A summary of meta-analyses of therapies for postmenopausal osteoporosis 2002
• Follow-up endoscopy study comparing risedronate and alendronate in postmenopausal women stratified by H. pylori status 2001
• Histomorphometric analysis of bone remodelling in patients with metastatic breast carcinoma 2001
• Risedronate is well-tolerated in postmenopausal women who are GI-intolerant to alendronate 2001
• The effects of treatment interventions on health related quality of life (HRQL) in post-menopausal women registered in the Canadian Database of Osteoporosis and Osteopenia (CANDOO) patients 2001
• Electron microscopic analyses of early mineral deposits in the calcifying epiphyseal growth plate 1985
• Mechanotransduction pathways regulating YAP nuclear translocation under Yoda1 and vibration in osteocytes..  190:117283. 2025
• Prevalence and incidence of Paget's disease of bone: Temporal trend over 20 years in the province of Quebec, Canada.  176:116895-116895. 2023
• Bone structure and composition in a hyperglycemic, obese, and leptin receptor-deficient rat: Microscale characterization of femur and calvarium.  172:116747-116747. 2023
• Development of a manufacturer-independent convolutional neural network for the automated identification of vertebral compression fractures in vertebral fracture assessment images using active learning.  161:116427-116427. 2022
• A search for apatite crystals in the gap zone of collagen fibrils in bone using dark-field illumination.  135:115304-115304. 2020
• Frailty and risk of osteoporotic fractures in patients with rheumatoid arthritis: Data from the Ontario Best Practices Research Initiative.  127:129-134. 2019
• Maternal and child factors associated with bone length traits in children at 3 years of age.  127:1-8. 2019
• Increased bone matrix mineralization in treatment-naïve children with inflammatory bowel disease.  105:50-56. 2017
• Bone lead (Pb) content at the tibia is associated with thinner distal tibia cortices and lower volumetric bone density in postmenopausal women.  79:58-64. 2015
• Comparison between frailty index of deficit accumulation and fracture risk assessment tool (FRAX) in prediction of risk of fractures.  77:107-114. 2015
• Ten-year incident osteoporosis-related fractures in the population-based Canadian Multicentre Osteoporosis Study — Comparing site and age-specific risks in women and men.  71:237-243. 2015
• Monitoring bone strontium intake in osteoporotic females self-supplementing with strontium citrate with a novel in-vivo X-ray fluorescence based diagnostic tool.  61:48-54. 2014
• The plastic nature of the human bone–periodontal ligament–tooth fibrous joint.  57:455-467. 2013
• Parathyroid hormone-related protein (PTHrP) modulates adhesion, migration and invasion in bone tumor cells.  55:198-207. 2013
• Bone mineralization is elevated and less heterogeneous in adults with type 2 diabetes and osteoarthritis compared to controls with osteoarthritis alone.  54:76-82. 2013
• Accumulation of bone strontium measured by in vivo XRF in rats supplemented with strontium citrate and strontium ranelate.  52:63-69. 2013
• Angiogenesis is required for stress fracture healing in rats.  52:212-219. 2013
• Giant cell tumor of bone: A basic science perspective.  52:238-246. 2013
• Characteristics associated with anti-osteoporosis medication use: Data from the Global Longitudinal Study of Osteoporosis in Women (GLOW) USA cohort.  51:975-980. 2012
• Antidepressant medications and osteoporosis.  51:606-613. 2012
• Monitoring bone strontium levels of an osteoporotic subject due to self-administration of strontium citrate with a novel diagnostic tool, in vivo XRF: A case study.  51:93-97. 2012
• Effect of co-morbidities on fracture risk: Findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).  50:1288-1293. 2012
• Regional differences in treatment for osteoporosis. The Global Longitudinal Study of Osteoporosis in Women (GLOW).  49:493-498. 2011
• Health-related quality of life and treatment of postmenopausal osteoporosis: Results from the HORIZON-PFT.  48:1298-1304. 2011
• Cortical and trabecular bone at the radius and tibia in postmenopausal breast cancer patients: A Peripheral Quantitative Computed Tomography (pQCT) study.  48:218-224. 2011
• The efficacy of a locally injectable prostaglandin EP-2 receptor agonist on fracture healing.  47:S71-S71. 2010
• Upregulation of MMP-13 via Runx2 in the stromal cell of Giant Cell Tumor of Bone.  45:377-386. 2009
• Collagenase expression and activity in the stromal cells from giant cell tumour of bone.  44:865-871. 2009
• Stress fracture healing: Fatigue loading of the rat ulna induces upregulation in expression of osteogenic and angiogenic genes that mimic the intramembranous portion of fracture repair.  44:320-330. 2009
• Geographic variation of bone mineral density and selected risk factors for prediction of incident fracture among Canadians 50 and older.  43:672-678. 2008
• Sex-specific developmental changes in muscle size and bone geometry at the femoral shaft.  42:982-989. 2008
• Evaluation of densitometric bone–muscle relationships in Crohn's disease.  40:1610-1614. 2007
• Juvenile onset of Crohn's disease: A risk factor for reduced lumbar bone mass in premenopausal women.  40:1290-1293. 2007
• In vivo skeletal imaging of 18F-fluoride with positron emission tomography reveals damage- and time-dependent responses to fatigue loading in the rat ulna.  39:229-236. 2006
• In vivo skeletal imaging of ¹⁸F-fluoride with positron emission tomography reveals damage- and time-dependent responses to fatigue loading in the rat ulna.  39:229-236. 2006
• A comparison of bone geometry and cortical density at the mid-femur between prepuberty and young adulthood using magnetic resonance imaging.  33:771-778. 2003
• Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial.  33:522-532. 2003
• Morphological, histomorphometric, and microstructural alterations in human bone metastasis from breast carcinoma.  31:529-535. 2002
• Bone mineral and material properties in children with insulin-dependent diabetes mellitus (IDDM): influence of exercise..  27:15-15. 2000
• Skeletal adaptations to intense exercise in prepubertal boys.  27:17-17. 2000
• Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis.  27:311-318. 2000
• Relationship between bone density and osteoarthritis in a skeletal population from London.  22:279-283. 1998
• Mineral induction by immobilized phosphoproteins.  21:305-311. 1997

has subject area

• 06 Biological Sciences (FoR)
• 09 Engineering (FoR)
• 11 Medical and Health Sciences (FoR)
• Endocrinology & Metabolism (Science Metrix)

Identity

International Standard Serial Number (ISSN)

• 0163-769X
• 2326-5191
• 8756-3282

Electronic International Standard Serial Number (EISSN)

• 1873-2763
• 1945-7189
• 2326-5205